ライフサイエンスコーパス: YAG

1 YAG laser vitreolysis subjectively improved Weiss ring-r

2 YAG vitreolysis is an untested treatment for floaters.

3 2 of the 5' GU, and all positions of the 3' YAG.

4 itical sequences at both the 5' (GU) and 3' (YAG) ends of the intron.

5 that were induced by mutations outside the 3'YAG consensus (designated 'de novo') were in introns.

6 as those resulting from a mutation of the 3'YAG consensus, were more frequent in exons than in intro

7 to experimental data on a sensitized Nd(3+):YAG cavity, and quantitative agreement with theoretical

8 ometrists submitted a total of 7521 and 3751 YAG laser capsulotomy claims to Medicare, respectively.

9 distribution identifies the optimal motif 5'-YAG-3' and shows how its copy number, position in the lo

10 rists who submitted claims to Medicare for a YAG laser capsulotomy, and the county addresses of the c

11 yes (82.5%), and 42 eyes (52.5%) underwent a YAG laser capsulotomy at a mean of 10.8 months after sur

12 s plana vitrectomy, phacoemulsification, and YAG capsulotomy into one procedure.

13 Ce:YAG nanostructures (Ce:YAG = Cerium in Yttrium Aluminium

14 Ce:YAG nanostructures (Ce:YAG = Cerium in Yttrium Aluminium Garnet), easy to contr

15 in absence of a template, extremely pure Ce:YAG nanoparticle (45 +/- 5 nm) can be also prepared, hig

16 We report a 750-mum-thick Nd(3+)-doped YAG planar waveguide sensitized by a luminescent CdSe/Cd

17 al application of nanosized rare-earth doped YAG on large scale.

18 A low-energy YAG laser was applied to remove the opacity.

19 Er:YAG laser has an excellent biofilm removal capability co

20 Er:YAG laser treatment is an effective method for reducing

21 Er:YAG laser treatment of titanium and zirconia implant sur

22 able response rates (CO2 laser, 50%-100%; Er:YAG laser, 72%-100%; PDL, 47%-100%; and Nd:YAG laser, 46

23 newed method comprises the output of an a Er:YAG laser at lambda = 2.94 mum which is in resonance wit

24 gher surface roughness was achieved after Er:YAG laser treatment.

25 All Er:YAG parameter combinations that were evaluated as well a

26 rial with either a dental handpiece or an Er:YAG laser (350 mJ/pulse at 6 Hz) by raster-scanning the

27 on of the dentinal surface with either an Er:YAG laser (lambda = 2.94 microns) or a standard dental b

28 An Er:YAG laser coupled with a cooling stream of water effecti

29 ed from disposable 30-gauge needles to an Er:YAG laser.

30 This LRD technique utilizes an Er:YAG rotary Q-switched laser with an output wavelength of

31 Both diode and Er:YAG lasers gave excellent results in gingival hyperpigme

32 The (80 at.%) Er:YAG crystal is opaque between 1.45 mum and 1.64 mum.

33 4 W, continuous wave),and "brushstroke" (Er:YAG laser, 180 mJ, 10 Hz, long pulse) techniques.

34 ival debridement followed 1 week later by Er:YAG application in sites with initial probing depths [PD

35 oablative deepithelialization with either Er:YAG or diode laser.

36 al tip is less efficient than high-energy Er:YAG irradiation to remove the plaque and TiO2 layer on a

37 5 groups: HF (hydrofluoric acid-etching), Er:YAG laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG las

38 gave statistically significant values for Er:YAG laser depigmentation (P = 0.001).

39 either an erbium:yttrium-aluminum-garnet (Er:YAG) (2,940-nm) laser or a diode (660-nm) laser in combi

40 l lasers, erbium:yttrium-aluminum-garnet (Er:YAG) and diode, for the treatment of gingival hyperpigme

41 ficacy of erbium:yttrium-aluminum-garnet (Er:YAG) laser application as an adjunct to subgingival debr

42 versus an erbium:yttrium-aluminum-garnet (Er:YAG) laser on titanium surfaces contaminated with subgin

43 bium-doped:yttrium, aluminum, and garnet (Er:YAG) laser techniques for gingival depigmentation and to

44 de (CO2), erbium:yttrium-aluminum-garnet (Er:YAG), pulsed dye (PDL), and Nd:YAG have been investigate

45 d-etching), Er:YAG laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG

46 CC) in 2 cases using RCM imaging to guide Er:YAG laser ablation.

47 ation remains the gold standard; however, Er:YAG laser and CO2 lasers can be effectively used but wit

48 However, Er:YAG laser induced deeper gingival tissue injury than dio

49 of mitomycin C (MMC), a novel Ab-Interno Er:YAG laser probe was inserted into the anterior chamber (

50 A 2.94-microm Er:YAG laser for IR atmospheric pressure matrix-assisted la

51 its of its applicability in an example of Er:YAG and Er:YLF dielectric crystals-potential radiation c

52 uld be performed only for the efficacy of Er:YAG laser due to the heterogeneity of the studies and th

53 as to evaluate the adjunctive benefits of Er:YAG laser irradiation for regenerative surgical therapy

54 the test group was the adjunctive use of Er:YAG laser to modulate and remove inflammatory tissue as

55 with an ultrasonic scaler (metal tip) or Er:YAG laser (20.3 or 38.2 J/cm(2)) in non-contact mode.

56 ce does suggest that use of the Nd:YAG or Er:YAG wavelengths for treatment of chronic periodontitis m

57 on the "laser" factor were in the order: Er:YAG > Nd:YAG (p < 0.05), and on the "graphite" factor we

58 The Dunnett test showed that Er:YAG + HF had significantly higher tensile strength (p =

59 We conclude that Er:YAG laser preparation of dentin leaves a suitable surfac

60 Furthermore, we observed that the Er:YAG capability of biofilm removal is not only due to its

61 and scanty plaque aggregates, whereas the Er:YAG laser (38.2 J/cm(2)) completely stripped away the pl

62 e ultrasonic scaler and </=0.03% with the Er:YAG laser (38.2 J/cm(2)).

63 The Er:YAG laser light resonantly excites O-H stretching vibrat

64 of 35 (28.6%) and six of 20 (30%) of the Er:YAG-laser-treated; and eight of 35 (22.8%) and four of 2

65 Thus Er:YAG laser treatment produces higher bond strength to res

66 showed additional advantages compared to Er:YAG in terms of less postoperative discomfort and pain.

67 n vitro and in vivo) experiment utilizing Er:YAG laser on titanium and zirconia discs was performed.

68 g full-mouth subgingival debridement with Er:YAG laser application in the treatment of patients with

69 titanium and zirconia discs treated with Er:YAG laser resulted in visual surface alterations, but sh

70 Newer wavelengths such as erbium:YAG are currently impractical.

71 To evaluate YAG laser vitreolysis vs sham vitreolysis for symptomati

72 procedures, such as yttrium aluminum garnet (YAG) capsulotomies or reduction of astigmatism and refra

73 ned yellow phosphor yttrium aluminum garnet (YAG) doped with trivalent cerium has found its way into

74 and neodymium-doped yttrium-aluminum-garnet (YAG) laser capsulotomy, and surgical complications.

75 imity to his or her yttrium-aluminum-garnet (YAG) laser capsulotomy-providing ophthalmologist and opt

76 id-infrared holmium:yttrium-aluminum-garnet (YAG) laser has been shown to be effective in a variety o

77 n-ion laser, 532-nm yttrium-aluminum-garnet (YAG) laser, blue fluorescent light bulb, or blue light-e

78 ry driving distances and times to his or her YAG laser capsulotomy-providing Oklahoma ophthalmologist

79 eshold illuminance with both Nd: YAG and Ho: YAG was ineffective.

80 The Ho: YAG laser-treated surface (wavelength 2100 nm) did not s

81 0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse.

82 e six treated with balloon dilatation and Ho:YAG laser endoureterotomy, the success rate was 67% (58

83 Holmium:yttrium-aluminum-garnet (Ho:YAG) laser endoureterotomy is useful for other types of

84 nd holmium doped yttrium-aluminum-garnet (Ho:YAG) laser.

85 tion and two with balloon dilatation plus Ho:YAG laser endoureterotomy, all successfully (57 months m

86 Our results suggest that Ho:YAG laser endoureterotomy should be a first line treatme

87 It is speculated that the Ho:YAG laser is coupling with absorbed water, and that the

88 2 kidney transplant patients managed with Ho:YAG laser endoureterotomy and/or percutaneous ureterosco

89 s were randomly assigned PTMR with a holmium:YAG laser plus continued medical treatment (n=110) or co

90 al ischemia is seen after TMR with a holmium:YAG laser.

91 ed in the left ventricle (LV) with a holmium:YAG laser.

92 n the anterior left ventricle with a Holmium:YAG laser.

93 +/-9.4% of baseline, p = 0.02) after holmium:YAG TMR.

94 Both holmium:YAG and CO2 lasers are associated with increased MWC and

95 ent holmium:yttrium-aluminum-garnet (holmium:YAG) (n = 12) or carbon dioxide (CO2) (n = 12) laser TMR

96 h a holmium:yttrium-aluminum-garnet (holmium:YAG) laser (n = 5), TMI (n = 5), or sham redo-thoracotom

97 The safety and efficacy of holmium:YAG laser lithotripsy make it the intracorporeal lithotr

98 (217.4+/-44.2% of baseline 6 h post-holmium:YAG TMR, p = 0.05; 206+/-36.7% of baseline 6 h post-CO2

99 The holmium:YAG (Yttrium-Aluminum-Garnet) laser lithotripter is able

100 The holmium:YAG laser lithotripter is the method of choice for flexi

101 ase in MWC (1.4+/-0.3% increase with holmium:YAG, p = 0.004; 1+/-0.2% increase with CO2, p = 0.002) a

102 owed significantly lower PCO rates and lower YAG rates compared to the AcrySof SN60WF IOL.

103 sing that the development of nanocrystalline YAG:Ce is not as mature as for these other materials.

104 peratures from 1900 to 3200 kelvin with a Nd-YAG laser in diamond-anvil cells to study the phase rela

105 s, pulse duration 0.2 ms) obtained from a Nd-YAG laser, which heated the fiber and bathing buffer sol

106 -II window close to the 1064 nm output of Nd-YAG lasers used for PAI.

107 Cells were irradiated with a pulsed Nd/YAG laser at 355 nm using 0-160 J per cm2.

108 ed on the surface after application of a Nd: YAG laser interference pattern to a surface that was fir

109 difference (P < 0.05) between IOP before Nd: YAG laser capsulotomy (16 mmHg +/- 3 mmHg) and the respe

110 t layer, threshold illuminance with both Nd: YAG and Ho: YAG was ineffective.

111 , in a period of 2 to 6 months following Nd: YAG laser caspulotomy.

112 neodymium-doped yttrium aluminum garnet (ND: YAG) laser capsulotomy without complications.

113 ion spectra using a frequency-quadrupled Nd: YAG laser on samples of NO, O2, and methyl iodide; a use

114 3 nC electron beam with a near infra-red Nd: YAG laser pulse containing ~ 100 mJ in a single shot bas

115 The Nd: YAG laser (wavelength 1060 nm) produced significant recr

116 and the time from cataract operation to Nd: YAG capsulotomy was compared.

117 different times from cataract surgery to Nd: YAG capsulotomy.

118 included 1045 eyes treated for PCO using Nd: YAG laser capsulotomy in the Hospital of Lithuanian Univ

119 Nd:YAG laser capsulotomy rates were compared between patien

120 Nd:YAG laser goniopuncture was done in cases where the intr

121 Nd:YAG laser hyaloidotomy and oral carbonic anhydrase inhib

122 Nd:YAG laser hyaloidotomy is an inexpensive, effective and

123 Nd:YAG laser hyaloidotomy was successful in 19 eyes(86.4%).

124 Nd:YAG treatment was performed on 9.9% of the eyes.

125 nderwent treatment with CO2 laser (n=18), Nd:YAG laser (n=18), or sham thoracotomy control (n=10) to

126 he standard MALDI lasers emitting at 355 (Nd:YAG) or 337 nm (N(2) laser).

127 3) CO2 laser with char layer removed; 4) Nd:YAG laser with air/water surface cooling, and char layer

128 2); 4) CO2 laser at 6 W (1,032 J/cm2); 5) Nd:YAG laser at 5 W (714 J/cm2); and 6) Nd:YAG laser at 7 W

129 urface cooling, and char layer intact; 5) Nd:YAG laser with air/water surface cooling, and char layer

130 ) Nd:YAG laser at 5 W (714 J/cm2); and 6) Nd:YAG laser at 7 W (1,000 J/cm2).

131 e cooling, and char layer removed; and 6) Nd:YAG laser without air/water surface cooling, and char la

132 er ablation with the second harmonic of a Nd:YAG laser (532 nm) at 13.5 mJ/pulse and a repetition rat

133 th an interference pattern generated by a Nd:YAG laser allows the activation of 1.7-micron-wide bands

134 fingerprinting of saliva, thereby using a Nd:YAG laser and Xevo G2-XS QToF-MS.

135 antly, CyB suffers photobleaching under a Nd:YAG laser but the signal decrease is <2% with the low-po

136 Frequency doubling of a Nd:YAG laser line resulted in a colinear beam of both lambd

137 A Nd:YAG laser with wavelengths of 532 nm or 1064 nm was used

138 A Nd:YAG operating at lambda=532 nm and an energies per pulse

139 es with PCO increased significantly after Nd:YAG laser capsulotomy, as shown by AS-OCT, a reliable an

140 Three days after Nd:YAG laser capsulotomy, mean ACD, AOD500, AOD750, and ACA

141 mography (AS-OCT) before and 3 days after Nd:YAG laser capsulotomy.

142 veloped chronic open-angle glaucoma after Nd:YAG vitreolysis for symptomatic floaters presenting with

143 postoperatively, 11.4% of patients had an Nd:YAG capsulotomy in the Vivinex XY1 eye and 18.6% had a c

144 b strongly near the second harmonic of an Nd:YAG laser (532 nm), hold promise for manipulating and in

145 of the magnetooptical (MO) Q-switch in an Nd:YAG laser cavity is performed.

146 The PCO scores and Nd:YAG capsulotomy rate.

147 ere risk factors for IOL decentration and Nd:YAG capsulotomy.

148 um-garnet (Er:YAG), pulsed dye (PDL), and Nd:YAG have been investigated as alternative treatments for

149 interventions including IOL exchange and Nd:YAG laser anterior capsulotomy.

150 response was severely delayed by CO2 and Nd:YAG laser irradiation of bone, even in the presence of a

151 ting from continuous mode shallow CO2 and Nd:YAG laser pulmonary parenchymal exposures applied in rab

152 nd without removal of the char layer, and Nd:YAG laser with char layer removed and with and without u

153 r:YAG laser, 72%-100%; PDL, 47%-100%; and Nd:YAG laser, 46%-100%).

154 erface during laser ablation with CO2 and Nd:YAG lasers used with and without (w/wo) air/water coolan

155 CO2 and Nd:YAG lasers were used w/wo coolant at power settings of 4

156 tudied for this purpose are CO2, PDL, and Nd:YAG, and of these, PDL has the fewest adverse effects.

157 Before Nd:YAG laser capsulotomy, mean ACD, AOD500, AOD750, and ACA

158 A compact Nd:YAG laser with an output at 1.06 microns corresponding t

159 s were first optically trapped (with a CW Nd:YAG laser at 1064 nm) and then photolyzed with a single

160 that uses a Q-switched, frequency-doubled Nd:YAG (neodymium, yttrium, aluminum, garnet) laser operati

161 phic recording, using a frequency-doubled Nd:YAG laser (532 nm).

162 phic recording, using a frequency doubled Nd:YAG laser (532 nm).

163 asmon absorption with a frequency doubled Nd:YAG laser (lambda = 532 nm) results in optically directe

164 NA FSFC using a compact frequency-doubled Nd:YAG laser excitation source.

165 A frequency-doubled Nd:YAG laser pulse was focused at the interface of the glas

166 aphic recording using a frequency-doubled Nd:YAG laser.

167 de) or photodisruptive (frequency doubled Nd:YAG) lasers, is still reserved for patients who do not i

168 Diabetes and an early Nd:YAG-caps after cataract surgery were among the main driv

169 This study evaluated Nd:YAG laser effects by comparing participants with vitreou

170 th untreated eyes with vitreous floaters, Nd:YAG-treated eyes had 23% less vitreous echodensity (P <

171 isual outcome and complications following Nd:YAG laser hyaloidotomy for premacular subhyaloid hemorrh

172 sure range from 18 to 38 months following Nd:YAG vitreolysis.

173 uence the total-pulse energy required for Nd:YAG capsulotomy.

174 econdary cataract) and hence the need for Nd:YAG laser posterior capsulotomy.

175 othesized that lung injury is deeper from Nd:YAG laser exposures than CO2 exposures because of deeper

176 neodymium-doped yttrium aluminium garnet (Nd:YAG) capsulotomy rate of a square-edge (SE) polymethylme

177 rt the neodymium:yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy rate (%) of eight rigid

178 neodymium-doped yttrium aluminum garnet (Nd:YAG) laser pulse device used to perform skin resurfacing

179 Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser treatment is performed on vitreous floaters,

180 neodymium-doped yttrium aluminum garnet (ND:YAG) laser was used to create light burns on the retina

181 r + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG laser + HF.

182 laser" factor were in the order: Er:YAG > Nd:YAG (p < 0.05), and on the "graphite" factor were in the

183 d picosecond 532 nm green second-harmonic Nd:YAG, and the femtosecond NIR 800 nm Ti:sapphire laser wi

184 laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG laser + HF.

185 Relatively high Nd:YAG laser posterior capsulotomy rates ranging from 20.3%

186 ng a frequency doubled Q-switched (10 Hz) Nd:YAG laser at 532 nm.

187 ding of the photodisruptive mechanisms in Nd:YAG capsulotomy.

188 The difference in Nd:YAG rates among the eight IOL designs was found to be si

189 Ablative treatments, including Nd:YAG laser, photodynamic therapy, and thermal contact tre

190 nder nanosecond-pulsed laser irradiation (Nd:YAG, 355 nm), the efficiency of Au cluster ion formation

191 higher risk of AEs than those with later Nd:YAG-caps (hazard ratio [HR], 1.314 [1.034-1.669], P = 0.

192 tiple pulses from a 3 x omega mode-locked Nd:YAG laser, columnar structures were formed on the surfac

193 optic apposition is associated with lower Nd:YAG capsulotomy rate and superior visual quality.

194 steroids resulted in significantly lower Nd:YAG capsulotomy rates compared to NSAIDs (hazard ratio [

195 le IOLs were associated with a much lower Nd:YAG laser posterior capsulotomy rate (14.1% vs. 31.1%).

196 acrylic materials had significantly lower Nd:YAG laser posterior capsulotomy rates ranging from 0.9%

197 high-repetition-rate (36.6 kHz) microchip Nd:YAG laser.

198 roseconds within plasmas formed by 300-mJ Nd:YAG laser pulses.

199 Therefore, a nanosecond Nd:YAG laser beam was focused into a flux of helium charged

200 , small, and "turn-key" Q-switched 532-nm Nd:YAG laser as a source for nonlinear, direct-write protei

201 inoculation site with a low power 532 nm Nd:YAG laser enhanced the permeability of the capillary ben

202 Rabbits were irradiated with a 532-nm Nd:YAG laser with a beam diameter of 330 microm at the reti

203 alexandrite laser, or Q-switched 1064-nm Nd:YAG laser.

204 e (FTICR) mass spectrometer with a 355-nm Nd:YAG UV laser, in the positive ion mode.

205 due to the isotropic crystal structure of Nd:YAG and the fact that the MO Q-switch incorporating the

206 The 5-year cumulative incidence of Nd:YAG capsulotomy after cataract surgery was 13.2% (95% co

207 suggests that the cumulative incidence of Nd:YAG capsulotomy is significantly lower in eyes receiving

208 Increased risk of Nd:YAG capsulotomy was associated with eyes of patients age

209 The cumulative incidence of Nd:YAG capsulotomy was estimated with competing risks metho

210 The 5-year incidence of Nd:YAG laser capsulotomy in this cohort was determined thro

211 cidence of PCO and hence the incidence of Nd:YAG laser posterior capsulotomy is now rapidly decreasin

212 e was given to the presence or absence of Nd:YAG laser posterior capsulotomy orifice on the posterior

213 ipants, a prospective randomized study of Nd:YAG laser treatment of vitreous is warranted, using unif

214 open-angle glaucoma is a complication of Nd:YAG vitreolysis for symptomatic floaters that may presen

215 xposures because of deeper penetration of Nd:YAG wavelength light.

216 rbonic anhydrase inhibitors (P = .016) or Nd:YAG laser hyaloidotomy (P = .007), and without a history

217 During the study period, Nd:YAG-caps were performed in 8,425 patients accounting for

218 re the most frequent AEs of interest post-Nd:YAG-caps, mainly observed within 3 months postprocedure,

219 8.4% of AEs occurred within 3 months post-Nd:YAG-caps.

220 cipants with vitreous floaters previously Nd:YAG-treated.

221 In order to understand a pulsed Nd:YAG laser at the fundamental frequency (lambda = 1,064 n

222 The design is based on a pulsed Nd:YAG laser which takes advantage of gating techniques to

223 ike heat loading was applied via a pulsed Nd:YAG millisecond laser on a pristine molybdenum (Mo) surf

224 quasi-continuous-wave (QCW) diode-pumped Nd:YAG laser cavity, which is shortened to 10 mm in length

225 e from a Q-switched, frequency-quadrupled Nd:YAG laser that was modified to have an approximately fla

226 nm excimer or 266 nm frequency-quadrupled Nd:YAG lasers to ablate and ionize particles in a single st

227 is mediated using a frequency-quintupled Nd:YAG laser (213 nm) operated at a rather low laser fluenc

228 he application of a 1-kHz repetition rate Nd:YAG laser (355 nm, <500-ps pulse widths) for atmospheric

229 ontal therapy (NSPT), test sites received Nd:YAG laser (first entrance to pocket: 3 W, 100 mus, 20 Hz

230 ontal therapy (NSPT), test sites received Nd:YAG laser (first entrance to pocket: 3 W, 100 us, 20 Hz;

231 Eight eyes received Nd:YAG laser treatment.

232 the study period, 6210 patients received Nd:YAG-caps (7958 procedures).

233 zed tracheobronchial amyloidosis required Nd:YAG (neodymium:yttrium-aluminum-garnet) laser therapy fo

234 14 eyes (34.2%); 12 eyes (29.3%) required Nd:YAG capsulotomy.

235 ior capsule opacification (PCO) requiring Nd:YAG laser capsulotomy in a representative mixed cohort o

236 ents subsequently requiring/not requiring Nd:YAG laser capsulotomy.

237 ade by splitting and recombining a single Nd:YAG laser beam.

238 quency-doubled, diode-pumped, solid-state Nd:YAG laser for rapid and sensitive DNA fragment sizing.

239 (41 of 52 [79%]), followed by Q-switched Nd:YAG (30 of 52 [58%]).

240 A Q-switched Nd:YAG laser at 355 nm was used to ablate a high-alloy stai

241 he range of 200-975nm by using Q-switched Nd:YAG laser at 532nm (4ns, 10Hz) attached to echelle spect

242 nanosecond laser pulses from a Q-switched Nd:YAG laser at lambda = 532 nm to generate cavitation bubb

243 Q switched Nd:YAG laser was applied to create an opening in the poster

244 nsively studied device was the Q-switched Nd:YAG laser, which has shown promising results based on mu

245 laser pulses of 532 nm from a Q-switched Nd:YAG laser.

246 distinct and slightly deeper in CO2 than Nd:YAG-treated animals (p<0.02) despite the shallower depth

247 reas of direct exposure, and suggest that Nd:YAG laser exposure at these settings may cause shallower

248 anged from 8.0 to 11.1 degrees C with the Nd:YAG and 1.4 to 2.1 degrees C with the CO2.

249 defects in the rat tibia created with the Nd:YAG and CO2 in the presence of a surface cooling spray o

250 approximately 119 to 139 seconds for the Nd:YAG and CO2, respectively.

251 used lasers for dental procedures are the Nd:YAG and CO2.

252 es such as those by Raman-shifting of the Nd:YAG fundamentals, our approach has the advantage of bein

253 The Nd:YAG laser can be used to lyse residual cortex after unco

254 periodontal soft tissue surgery with the Nd:YAG laser could be damaging, especially if the exposure

255 The Nd:YAG laser posterior capsulotomy rate (%) as of January 2

256 In addition, the Nd:YAG laser posterior capsulotomy rate for each lens was p

257 n the total-pulse energy required for the Nd:YAG laser posterior capsulotomy.

258 Specimens treated with the Nd:YAG laser using an air/water surface coolant exhibited a

259 Before treatment with the Nd:YAG laser, all patients had subjective visual complaints

260 sed trapping wavelength, 1064 nm from the Nd:YAG laser, strongly reduced clonability, depending upon

261 The Nd:YAG LGP is a safe and effective procedure for lowering I

262 ent evidence does suggest that use of the Nd:YAG or Er:YAG wavelengths for treatment of chronic perio

263 n the total-pulse energy required for the Nd:YAG procedure was analyzed.

264 47 eyes with PCO scheduled for the Nd:YAG procedure were examined and divided into four catego

265 Among the modalities for its treatment, Nd:YAG laser hyaloidotomy is a non invasive method enabling

266 Patients who had undergone Nd:YAG laser capsulotomy were significantly younger (median

267 ior capsule opacification (PCO) underwent Nd:YAG laser capsulotomy.

268 Consecutive patients who underwent Nd:YAG laser treatment for residual cortex at the Kellogg E

269 with patent internal ostia and underwent Nd:YAG LGP, followed by a 5-fluorouracil injection.

270 French adult patients who underwent Nd:YAG-caps between 2014 and 2017 were selected.

271 ure to optical trapping wavelengths using Nd:YAG (1064 nm) and tunable titanium-sapphire (700-990 nm)

272 taract surgery and is mostly treated with Nd:YAG laser capsulotomy.

273 oup, participants previously treated with Nd:YAG laser for bothersome vitreous floaters showed less d

274 ary explosives that can be initiated with Nd:YAG laser light at lower energy thresholds than those of

275 floaters who previously were treated with Nd:YAG, 25 were dissatisfied and seeking vitrectomy, wherea

276 Cox models showed that patients with Nd:YAG-caps performed within 1 year after cataract surgery

277 Nine-year Nd:YAG capsulotomy rates were 2% for SE-PMMA IOLs versus 37

278 y with ST-LP with a frequency-doubled Neodym-YAG Laser and OCT imaging.

279 We used a Neodymium-YAG dual frequency laser to make the lesions.

280 ing frequency-doubled double-pulse neodymium:YAG laser lithotripsy.

281 avior is studied in erbium-doped Y3 Al5 O12 (YAG) garnets synthesized by solid-state reactions.

282 istance of time following the application of YAG laser capsulotomy.

283 s, particle sizes, and optical properties of YAG:Ce on the nanoscale.

284 striking effect on the optical properties of YAG:Er(3+) .

285 to undergo surgery, 40 (15.7%) required only YAG-Laser and 14 (5.5%) required a spectacle prescriptio

286 as cerium-doped yttrium aluminum garnet or (YAG):Ce(3+), coupled with a blue-emitting InGaN/GaN diod

287 Damage was intentionally created, performing YAG-pits (n = 5) in the central area of the lens optic (

288 concentrations of luminescent and scattering YAG:Ce microparticles, we systematically explored and qu

289 ly assigned to YAG laser vitreolysis or sham YAG (control).

290 The YAG laser group reported greater symptomatic improvement

291 e, 5.6; 95% CI, 0.5-10.8; P = .03) among the YAG laser group.

292 udy (mean [SD] age, 61.4 [8.0] years for the YAG laser group and 61.1 [6.6] years for the sham group)

293 visual acuity changed by -0.2 letters in the YAG laser group and by -0.6 letters in sham group (diffe

294 A total of 19 patients (53%) in the YAG laser group reported significantly or completely imp

295 In the YAG laser group, the 10-point visual disturbance score i

296 ther materials on the nanoscale, even though YAG:Ce microcrystalline materials exceed the performance

297 re was no difference in geographic access to YAG laser capsulotomy whether performed by an Oklahoma o

298 Patients were randomly assigned to YAG laser vitreolysis or sham YAG (control).

299 as a donor consensus in P. carinii, whereas YAG serves as an acceptor consensus.

300 laser of wavelength 10.6 mum and a Trumpf Yb-YAG disk laser of wavelength 1.030 mum were used with a